Terrance P. Coyne - Net Worth and Insider Trading
Terrance P. Coyne Net Worth
The estimated net worth of Terrance P. Coyne is at least $24 Million dollars as of 2024-04-27. Terrance P. Coyne is the EVP & CFO of Royalty Pharma PLC and owns about 840,390 shares of Royalty Pharma PLC (RPRX) stock worth over $24 Million. Details can be seen in Terrance P. Coyne's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Terrance P. Coyne has not made any transactions after 2023-08-10 and currently still holds the listed stock(s).
Transaction Summary of Terrance P. Coyne
Terrance P. Coyne Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Terrance P. Coyne owns 1 companies in total, including Royalty Pharma PLC (RPRX) .
Click here to see the complete history of Terrance P. Coyne’s form 4 insider trades.
Insider Ownership Summary of Terrance P. Coyne
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2023-08-10 | EVP & CFO |
Terrance P. Coyne Latest Holdings Summary
Terrance P. Coyne currently owns a total of 1 stock. Terrance P. Coyne owns 840,390 shares of Royalty Pharma PLC (RPRX) as of August 10, 2023, with a value of $24 Million.
Latest Holdings of Terrance P. Coyne
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RPRX | Royalty Pharma PLC | 2023-08-10 | 840,390 | 28.00 | 23,530,920 |
Holding Weightings of Terrance P. Coyne
Terrance P. Coyne Form 4 Trading Tracker
According to the SEC Form 4 filings, Terrance P. Coyne has made a total of 8 transactions in Royalty Pharma PLC (RPRX) over the past 5 years, including 1 buys and 7 sells. The most-recent trade in Royalty Pharma PLC is the sale of 75,000 shares on August 10, 2023, which brought Terrance P. Coyne around $2 Million.
Insider Trading History of Terrance P. Coyne
- 1
Terrance P. Coyne Trading Performance
GuruFocus tracks the stock performance after each of Terrance P. Coyne's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Terrance P. Coyne is -17.52%. GuruFocus also compares Terrance P. Coyne's trading performance to market benchmark return within the same time period. The performance of stocks bought by Terrance P. Coyne within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Terrance P. Coyne's insider trading performs compared to the benchmark.
Performance of Terrance P. Coyne
Average Return
-13.3%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -13.18 | -17.52 | -12.77 | -13.3 | -13.25 | -14.45 |
| Relative Return to S&P 500(%) | -16.69 | -24.07 | -31.84 | -47.04 | -21.87 | -26.75 |
Terrance P. Coyne Ownership Network
Ownership Network List of Terrance P. Coyne
Ownership Network Relation of Terrance P. Coyne
Terrance P. Coyne Owned Company Details
What does Royalty Pharma PLC do?
Who are the key executives at Royalty Pharma PLC?
Terrance P. Coyne is the EVP & CFO of Royalty Pharma PLC. Other key executives at Royalty Pharma PLC include 10 percent owner Avara Management Ltd , director & CEO & Chairman of the Board Pablo G. Legorreta , and EVP & Investments & GC George W. Lloyd .
Royalty Pharma PLC (RPRX) Insider Trades Summary
Over the past 18 months, Terrance P. Coyne made 4 insider transaction in Royalty Pharma PLC (RPRX) with a net sale of 180,000. Other recent insider transactions involving Royalty Pharma PLC (RPRX) include a net sale of 420,000 shares made by George W. Lloyd , a net sale of 2,479,950 shares made by Rory B Riggs , and a net purchase of 600,000 shares made by Pablo G. Legorreta .
In summary, during the past 3 months, insiders sold 0 shares of Royalty Pharma PLC (RPRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,484,548 shares of Royalty Pharma PLC (RPRX) were sold and 600,000 shares were bought by its insiders, resulting in a net sale of 3,884,548 shares.
Royalty Pharma PLC (RPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Royalty Pharma PLC Insider Transactions
Terrance P. Coyne Mailing Address
Above is the net worth, insider trading, and ownership report for Terrance P. Coyne. You might contact Terrance P. Coyne via mailing address: C/o Royalty Pharma Plc, 110 East 59th Street, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
